Skip to content

Clinical trials

Phase 2 Colitis, Ulcerative trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Colitis, Ulcerative Phase: Phase 2 Country / region: Netherlands Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20071
20081
20091
20113
20123
20135
20152
20165
20172
20181
20192
20201
20213
20223
20233
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Terminated7
Recruiting4
Active, not recruiting3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline4
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)3
Amgen3
Bristol-Myers Squibb3
Janssen Research & Development, LLC3
Eli Lilly and Company2
Lycera Corp.2
Pfizer2
Shire2
Takeda2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colitis, Ulcerative40
Inflammatory Bowel Diseases6
Crohn Disease4
Lymphoma, Follicular1
Proctitis1

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.